Abstract
A large number of patients are switched to second-line antiretroviral therapy, especially in resource limited settings. Lopinavir/Ritonavir is the main drug used in second-line treatment regimens. We describe a patient attending an HIV treatment centre in Kampala, Uganda, who presented with bilateral non-tender pitting inflammatory edema two weeks after switching to a Lopinavir/Ritonavir-containing second-line treatment regimen. The lack of an alternate explanation led us to suspect that Lopinavir/Ritonavir was potentially responsible for the edema.
Original language | English (US) |
---|---|
Pages (from-to) | 405-407 |
Number of pages | 3 |
Journal | Journal of infection in developing countries |
Volume | 3 |
Issue number | 5 |
DOIs | |
State | Published - 2009 |
Externally published | Yes |
Keywords
- Edema
- Lopinavir/Ritonavir
- Resource-limited setting
ASJC Scopus subject areas
- Parasitology
- Microbiology
- Infectious Diseases
- Virology